Treatment with T80/H25 was associated with a significantly greater mean reduction in BP compared with V160/H25 for both SBP (adjusted mean difference −2.7 mm Hg; 95% confidence interval (CI), −5.1, −0.3; P = 0.0265) and DBP (adjusted mean difference −2.0 mm Hg; 95% CI, −3.4, −0.6; P = 0.0041).
telmisartan 80 mg combined with hydrochlorothiazide (HCTZ) 25 mg
valsartan 160 mg combined with hydrochlorothiazide (HCTZ) 25 mg
DBP change among non-Black patients